Haemonetics Corp. Inc. (HAE) Price Performance: A Fundamental Analysis Perspective

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 5.80%. However, over the past six months, we’ve seen a stronger performance of -1.08%. The price of HAE leaped by -7.95% over the last 30 days. And in the last five days, it has fallen by -3.38%.

Currently, the stock price of Haemonetics Corp. (HAE) is $83.21. In the most recent trading session, the stock underwent a significant upswing, peaking at $89.315 after opening at $88.52. The stock touched a low of $82.355 before closing at $89.22.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Haemonetics Corp. had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $95.26 on 08/08/23, while the lowest price during the same period was $72.26 on 01/09/23.

52-week price history of HAE Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Haemonetics Corp.’s current trading price is -12.65% away from its 52-week high, while its distance from the 52-week low is 15.15%. The stock’s price range over this timeframe has been between $72.26 and $95.26. The shares of the Healthcare sector company recorded a trading volume of approximately 0.77 million for the day, which was comparatively higher than the average daily volume of 0.28 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Haemonetics Corp. (HAE) has experienced a quarterly decline of -2.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.22B and boasts a workforce of 3034 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 88.68, with a change in price of -0.85. Similarly, Haemonetics Corp. recorded 287,843 in trading volume during the last 100 days, posting a change of -1.01%.

HAE’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for HAE stands at 0.85. Similarly, the long-term debt-to-equity ratio is also 0.84.

HAE Stock Stochastic Average

The raw stochastic average for Haemonetics Corp. over the last 50 days is presently at 9.51%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 12.96%. Further, the company’s Stochastic %K and %D values for the last 20 days were 56.44% and 65.92%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts